Projected Income Statement: Vext Science, Inc.

Forecast Balance Sheet: Vext Science, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - 7.64 32.2 29.9 34.9 30.7 26 -
Change - - 321.47% -7.14% 16.72% -12.02% -15.31% -
Announcement Date 15/04/21 20/04/22 22/03/23 10/05/24 31/03/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Vext Science, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 4.063 18.78 8.86 2.737 1.465 3.3 1.2
Change - 362.26% -52.83% -69.11% -46.46% 125.21% -63.64%
Free Cash Flow (FCF) 1 -9.803 -7.102 -2.938 1.688 1.823 6.7 5.8
Change - 27.55% 58.64% 157.45% 8.04% 267.47% -13.43%
Announcement Date 15/04/21 20/04/22 22/03/23 10/05/24 31/03/25 - -
1CAD in Million
Estimates

Forecast Financial Ratios: Vext Science, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

         
EBITDA Margin (%) - 27.04% 35.96% 42.69% 15.88% 25.43% 23.88% 35.25% -
EBIT Margin (%) - 18.6% - - -22.53% -31.06% - - -
EBT Margin (%) - 10.48% - - - - -16.71% -7.8% 3.53%
Net margin (%) - 8.43% - - - - -22.59% -10.43% 1.02%
FCF margin (%) - -38.91% -19.07% -8.3% 4.85% 5.06% 13.01% 9.74% -
FCF / Net Income (%) - -461.28% - - - - -57.6% -93.39% -

Profitability

         
ROA 7.2% 4.29% 7.17% 5.67% -3.62% -5.04% - - -
ROE 13.09% 6.86% 10.42% 16.63% 5.27% -26.28% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - 0.57x 2.13x 5.4x 3.81x 2.5x 1.24x -
Debt / Free cash flow - - -1.08x -10.97x 17.7x 19.14x 4.58x 4.48x -

Capital Intensity

         
CAPEX / Current Assets (%) - 16.13% 50.43% 25.02% 7.86% 4.07% 6.41% 2.01% -
CAPEX / EBITDA (%) - 59.65% 140.24% 58.61% 49.52% 16.01% 26.83% 5.71% -
CAPEX / FCF (%) - -41.45% -264.47% -301.62% 162.18% 80.37% 49.25% 20.69% -

Items per share

         
Cash flow per share 1 - - 0.1008 0.0583 0.0367 0.0197 0.06 0.06 -
Change - - - -42.2% -37.04% -46.35% 204.72% 0% -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - 0.0251 - - 0.041 -0.115 -0.069 -0.042 -
Change - - - - - -380.53% 39.99% 39.13% -
Nbr of stocks (in thousands) - 115,153 136,713 148,963 217,484 247,443 247,684 247,684 247,684
Announcement Date - 15/04/21 20/04/22 22/03/23 10/05/24 31/03/25 - - -
1CAD
Estimates
2025 *2026 *
P/E ratio -3.26x -5.36x
PBR - -
EV / Sales 1.38x 1.11x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2250CAD
Average target price
0.6750CAD
Spread / Average Target
+200.00%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. VEXT Stock
  4. Financials Vext Science, Inc.